Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking approach to diabetes management. These innovative therapies function by mimicking the natural actions of GLP-1, a hormone secreted by the gut in response to meals. By triggering GLP-1 receptors in the pancreas, these agents enhance insulin release and suppress glucagon re

The management of diabetes is with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are gaining significant recognition. These medications offer promising approaches for controlling blood sugar levels and potentially improve the lives of individuals living with diabetes. This novel